mRNA VACCINE TECHNOLOGY TRANSFER AGREEMENTVaccine Technology Transfer Agreement • March 4th, 2024
WHEREAS, MPP, in collaboration with the World Health Organization (“WHO”), has established the mRNA Technology Transfer Hub Programme with the aim to establish or enhance sustainable mRNA vaccines manufacturing capacity in low- and middle-income countries (“LMICs”), in particular to improve the ability of such countries to better respond to the COVID-19 pandemic and other future pandemics;
mRNA VACCINE TECHNOLOGY TRANSFER AGREEMENTVaccine Technology Transfer Agreement • October 17th, 2022
WHEREAS, MPP, in collaboration with the World Health Organization (“WHO”), has established the mRNA Technology Transfer Hub Programme with the aim to establish or enhance sustainable mRNA vaccines manufacturing capacity in low- and middle-income countries (“LMICs”), in particular to improve the ability of such countries to better respond to the COVID-19 pandemic and other future pandemics;
mRNA VACCINE TECHNOLOGY TRANSFER AGREEMENTVaccine Technology Transfer Agreement • February 25th, 2024
THE MEDICINES PATENT POOL FOUNDATION, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at Rue de Varembé 7, CH-1202 Geneva (“MPP”); and
mRNA VACCINE TECHNOLOGY TRANSFER AGREEMENTVaccine Technology Transfer Agreement • March 16th, 2024
THE MEDICINES PATENT POOL FOUNDATION, a non-profit foundation registered under the laws of Switzerland, and having a principal place of business at Rue de Varembé 7, CH-1202 Geneva (“MPP”); and
mRNA VACCINE TECHNOLOGY TRANSFER AGREEMENTVaccine Technology Transfer Agreement • October 18th, 2022
incorporated under the laws of South Africa and having its registered office at 15 Alexandra Road, Pinelands, 7405, Cape Town, South Africa (“Biovac”),
